- Home
- POLA vs KLTO Comparison
POLA vs KLTO Comparison
Compare POLA & KLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- KLTO
- Stock Information
- Founded
- POLA 1979
- KLTO 2019
- Country
- POLA United States
- KLTO United States
- Employees
- POLA N/A
- KLTO N/A
- Industry
- POLA Industrial Machinery/Components
- KLTO
- Sector
- POLA Miscellaneous
- KLTO
- Exchange
- POLA Nasdaq
- KLTO NYSE
- Market Cap
- POLA 5.6M
- KLTO 5.0M
- IPO Year
- POLA 2016
- KLTO N/A
- Fundamental
- Price
- POLA $2.10
- KLTO $0.16
- Analyst Decision
- POLA
- KLTO
- Analyst Count
- POLA 0
- KLTO 0
- Target Price
- POLA N/A
- KLTO N/A
- AVG Volume (30 Days)
- POLA 15.9K
- KLTO 152.3K
- Earning Date
- POLA 05-14-2025
- KLTO 05-15-2025
- Dividend Yield
- POLA N/A
- KLTO N/A
- EPS Growth
- POLA N/A
- KLTO N/A
- EPS
- POLA N/A
- KLTO N/A
- Revenue
- POLA $13,970,000.00
- KLTO N/A
- Revenue This Year
- POLA N/A
- KLTO N/A
- Revenue Next Year
- POLA N/A
- KLTO N/A
- P/E Ratio
- POLA N/A
- KLTO N/A
- Revenue Growth
- POLA N/A
- KLTO N/A
- 52 Week Low
- POLA $1.78
- KLTO $0.11
- 52 Week High
- POLA $4.90
- KLTO $13.10
- Technical
- Relative Strength Index (RSI)
- POLA 40.75
- KLTO N/A
- Support Level
- POLA $2.02
- KLTO N/A
- Resistance Level
- POLA $2.27
- KLTO N/A
- Average True Range (ATR)
- POLA 0.15
- KLTO 0.00
- MACD
- POLA 0.02
- KLTO 0.00
- Stochastic Oscillator
- POLA 54.33
- KLTO 0.00
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.